Shenzhen University General Hospital

This study tests a new treatment for people with B-cell lymphoma that has returned or not responded to standard therapy. The treatment uses a patient's own immune cells, modified to target two markers on cancer cells. The goal is to control the disease, not cure it. About 20 adul…

This study is testing a new type of treatment called MSLN CAR-T cell therapy for people with advanced solid tumors that have spread or come back. Doctors will give a one-time infusion of specially modified immune cells to 20 participants to see if it is safe and if it can help co…